{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:34:27Z","timestamp":1792510467969,"version":"4.5.0"},"reference-count":180,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T00:00:00Z","timestamp":1626220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T00:00:00Z","timestamp":1626220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s10741-021-10139-0","type":"journal-article","created":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T15:03:50Z","timestamp":1626275030000},"page":"1173-1191","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":97,"title":["Dilated cardiomyopathy in the era of precision medicine: latest concepts and developments"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4755-9309","authenticated-orcid":false,"given":"Nicoletta","family":"Orphanou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efstathios","family":"Papatheodorou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aris","family":"Anastasakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,14]]},"reference":[{"issue":"2","key":"10139_CR1","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1093\/eurheartj\/ehm342","volume":"29","author":"P Elliott","year":"2007","unstructured":"Elliott P, Andersson B, Arbustini E et al (2007) Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial And Pericardial Diseases. Eur Heart J 29(2):270\u2013276. https:\/\/doi.org\/10.1093\/eurheartj\/ehm342","journal-title":"Eur Heart J"},{"issue":"23","key":"10139_CR2","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1093\/eurheartj\/ehv727","volume":"37","author":"YM Pinto","year":"2016","unstructured":"Pinto YM, Elliott PM, Arbustini E et al (2016) Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases. Eur Heart J 37(23):1850\u20131858. https:\/\/doi.org\/10.1093\/eurheartj\/ehv727","journal-title":"Eur Heart J"},{"key":"10139_CR3","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.ijcard.2018.01.002","volume":"257","author":"A Anastasakis","year":"2018","unstructured":"Anastasakis A, Basso C (2018) \u201cPrimary\u201d dilated hearts. Int J Cardiol 257:366\u2013370. https:\/\/doi.org\/10.1016\/j.ijcard.2018.01.002","journal-title":"Int J Cardiol"},{"issue":"5","key":"10139_CR4","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1161\/01.CIR.62.5.1054","volume":"62","author":"WL Henry","year":"1980","unstructured":"Henry WL, Gardin JM, Ware JH (1980) Echocardiographic measurements in normal subjects from infancy to old age. Circulation 62(5):1054\u20131061. https:\/\/doi.org\/10.1161\/01.CIR.62.5.1054","journal-title":"Circulation"},{"issue":"39","key":"10139_CR5","doi-asserted-by":"publisher","first-page":"3784","DOI":"10.1093\/eurheartj\/ehz908","volume":"41","author":"G Sinagra","year":"2020","unstructured":"Sinagra G, Elliott PM, Merlo M (2020) Dilated cardiomyopathy: so many cardiomyopathies! Eur Heart J 41(39):3784\u20133786. https:\/\/doi.org\/10.1093\/eurheartj\/ehz908","journal-title":"Eur Heart J"},{"issue":"14","key":"10139_CR6","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1161\/CIRCULATIONAHA.106.174287","volume":"113","author":"BJ Maron","year":"2006","unstructured":"Maron BJ, Towbin JA, Thiene G et al (2006) Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 113(14):1807\u20131816. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.174287","journal-title":"Circulation"},{"issue":"8","key":"10139_CR7","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1002\/ejhf.1534","volume":"21","author":"PM Elliott","year":"2019","unstructured":"Elliott PM, Anastasakis A, Asimaki A et al (2019) Definition and treatment of arrhythmogenic cardiomyopathy: an updated expert panel report. Eur J Heart Fail 21(8):955\u2013964. https:\/\/doi.org\/10.1002\/ejhf.1534","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"10139_CR8","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.jacc.2014.05.027","volume":"64","author":"E Arbustini","year":"2014","unstructured":"Arbustini E, Narula N, Tavazzi L et al (2014) The MOGE(S) classification of cardiomyopathy for clinicians. J Am Coll Cardiol 64(3):304\u2013318. https:\/\/doi.org\/10.1016\/j.jacc.2014.05.027","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10139_CR9","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s000590050001","volume":"25","author":"E Arbustini","year":"2000","unstructured":"Arbustini E, Morbini P, Pilotto A, Gavazzi A, Tavazzi L (2000) Genetics of idiopathic dilated cardiomyopathy. Herz 25(3):156\u2013160. https:\/\/doi.org\/10.1007\/s000590050001","journal-title":"Herz"},{"issue":"5","key":"10139_CR10","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nrg2983","volume":"12","author":"EE Creemers","year":"2011","unstructured":"Creemers EE, Wilde AA, Pinto YM (2011) Heart failure: advances through genomics. Nat Rev Genet 12(5):357\u2013362. https:\/\/doi.org\/10.1038\/nrg2983","journal-title":"Nat Rev Genet"},{"issue":"3","key":"10139_CR11","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1093\/eurheartj\/ehr260","volume":"33","author":"D Jacoby","year":"2012","unstructured":"Jacoby D, McKenna WJ (2012) Genetics of inherited cardiomyopathy. Eur Heart J 33(3):296\u2013304. https:\/\/doi.org\/10.1093\/eurheartj\/ehr260","journal-title":"Eur Heart J"},{"issue":"15","key":"10139_CR12","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/j.jacc.2008.06.044","volume":"52","author":"M Pasotti","year":"2008","unstructured":"Pasotti M, Klersy C, Pilotto A et al (2008) Long-term outcome and risk stratification in dilated cardiolaminopathies. J Am Coll Cardiol 52(15):1250\u20131260. https:\/\/doi.org\/10.1016\/j.jacc.2008.06.044","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10139_CR13","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00109-004-0589-1","volume":"83","author":"JH van Berlo","year":"2005","unstructured":"van Berlo JH, de Voogt WG, van der Kooi AJ et al (2005) Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A\/C mutations portend a high risk of sudden death? J Mol Med 83(1):79\u201383. https:\/\/doi.org\/10.1007\/s00109-004-0589-1","journal-title":"J Mol Med"},{"issue":"12","key":"10139_CR14","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1093\/eurjhf\/hfq175","volume":"12","author":"MP van den Berg","year":"2010","unstructured":"van den Berg MP, van Spaendonck-Zwarts KY, van Veldhuisen DJ, Gietema JA, Postma A, van Tintelen JP (2010) Familial dilated cardiomyopathy: another risk factor for anthracycline-induced cardiotoxicity? Eur J Heart Fail 12(12):1297\u20131299. https:\/\/doi.org\/10.1093\/eurjhf\/hfq175","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10139_CR15","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/oxfordjournals.eurheartj.a015092","volume":"18","author":"S Rakar","year":"1997","unstructured":"Rakar S, Sinagra G, Di Lenarda A et al (1997) Epidemiology of dilated cardiomyopathy: a prospective post-mortem study of 5252 necropsies. Eur Heart J 18(1):117\u2013123. https:\/\/doi.org\/10.1093\/oxfordjournals.eurheartj.a015092","journal-title":"Eur Heart J"},{"issue":"1","key":"10139_CR16","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/S0735-1097(97)00434-8","volume":"31","author":"E Gr\u00fcnig","year":"1998","unstructured":"Gr\u00fcnig E, Tasman JA, K\u00fccherer H, Franz W, K\u00fcbler W, Katus HA (1998) Frequency and phenotypes of familial dilated cardiomyopathy. J Am Coll Cardiol 31(1):186\u2013194. https:\/\/doi.org\/10.1016\/S0735-1097(97)00434-8","journal-title":"J Am Coll Cardiol"},{"key":"10139_CR17","doi-asserted-by":"publisher","unstructured":"Bozkurt B, Colvin M, Cook J et al (2016) Current diagnostic and treatment strategies for specific dilated cardiomyopathies: a scientific statement from the American Heart Association. Circulation 134(23). https:\/\/doi.org\/10.1161\/CIR.0000000000000455","DOI":"10.1161\/CIR.0000000000000455"},{"issue":"1","key":"10139_CR18","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0735-1097(99)00172-2","volume":"34","author":"L Mestroni","year":"1999","unstructured":"Mestroni L, Rocco C, Gregori D et al (1999) Familial dilated cardiomyopathy. J Am Coll Cardiol 34(1):181\u2013190. https:\/\/doi.org\/10.1016\/S0735-1097(99)00172-2","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10139_CR19","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1517\/21678707.2015.1057498","volume":"3","author":"ME Sweet","year":"2015","unstructured":"Sweet ME, Taylor MR, Mestroni L (2015) Diagnosis, prevalence, and screening of familial dilated cardiomyopathy. Expert Opin Orphan Drugs 3(8):869\u2013876. https:\/\/doi.org\/10.1517\/21678707.2015.1057498","journal-title":"Expert Opin Orphan Drugs"},{"issue":"16","key":"10139_CR20","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1016\/j.jacc.2011.01.015","volume":"57","author":"RE Hershberger","year":"2011","unstructured":"Hershberger RE, Siegfried JD (2011) Update 2011: Clinical and genetic issues in familial dilated cardiomyopathy. J Am Coll Cardiol 57(16):1641\u20131649. https:\/\/doi.org\/10.1016\/j.jacc.2011.01.015","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10139_CR21","first-page":"1074","volume":"19","author":"A Dolara","year":"1989","unstructured":"Dolara A, Cecchi F, Ciaccheri M (1989) Cardiomyopathy in Italy today: extent of the problem. G Ital Cardiol 19(11):1074\u20131079","journal-title":"G Ital Cardiol"},{"issue":"1","key":"10139_CR22","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1093\/oxfordjournals.aje.a115484","volume":"131","author":"SS Coughlin","year":"1990","unstructured":"Coughlin SS, Szklo M, Baughman K, Pearson TA (1990) The epidemiology of idiopathic dilated cardiomyopathy in a biracial community. Am J Epidemiol 131(1):48\u201356. https:\/\/doi.org\/10.1093\/oxfordjournals.aje.a115484","journal-title":"Am J Epidemiol"},{"issue":"20","key":"10139_CR23","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1093\/eurheartj\/ehx819","volume":"39","author":"P Charron","year":"2018","unstructured":"Charron P, Elliott PM, Gimeno JR et al (2018) The Cardiomyopathy Registry of the EURObservational Research Programme of the European Society of Cardiology: baseline data and contemporary management of adult patients with cardiomyopathies. Eur Heart J 39(20):1784\u20131793. https:\/\/doi.org\/10.1093\/eurheartj\/ehx819","journal-title":"Eur Heart J"},{"issue":"18","key":"10139_CR24","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1016\/j.jacc.2013.12.021","volume":"63","author":"JJ Goldberger","year":"2014","unstructured":"Goldberger JJ, Suba\u010dius H, Patel T, Cunnane R, Kadish AH (2014) Sudden cardiac death risk stratification in patients with nonischemic dilated cardiomyopathy. J Am Coll Cardiol 63(18):1879\u20131889. https:\/\/doi.org\/10.1016\/j.jacc.2013.12.021","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10139_CR25","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.ahj.2007.07.038","volume":"154","author":"JP van Tintelen","year":"2007","unstructured":"van Tintelen JP, Hofstra RMW, Katerberg H et al (2007) High yield of LMNA mutations in patients with dilated cardiomyopathy and\/or conduction disease referred to cardiogenetics outpatient clinics. Am Heart J 154(6):1130\u20131139. https:\/\/doi.org\/10.1016\/j.ahj.2007.07.038","journal-title":"Am Heart J"},{"issue":"3","key":"10139_CR26","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1093\/europace\/euw362","volume":"20","author":"A Anastasakis","year":"2018","unstructured":"Anastasakis A, Papatheodorou E, Ritsatos K et al (2018) Sudden unexplained death in the young: epidemiology, aetiology and value of the clinically guided genetic screening. EP Eur 20(3):472\u2013480. https:\/\/doi.org\/10.1093\/europace\/euw362","journal-title":"EP Eur"},{"issue":"1","key":"10139_CR27","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41431-019-0500-8","volume":"28","author":"N Lahrouchi","year":"2020","unstructured":"Lahrouchi N, Raju H, Lodder EM et al (2020) The yield of postmortem genetic testing in sudden death cases with structural findings at autopsy. Eur J Hum Genet 28(1):17\u201322. https:\/\/doi.org\/10.1038\/s41431-019-0500-8","journal-title":"Eur J Hum Genet"},{"issue":"11","key":"10139_CR28","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.jacc.2018.01.031","volume":"71","author":"M Papadakis","year":"2018","unstructured":"Papadakis M, Papatheodorou E, Mellor G et al (2018) The diagnostic yield of Brugada syndrome after sudden death with normal autopsy. J Am Coll Cardiol 71(11):1204\u20131214. https:\/\/doi.org\/10.1016\/j.jacc.2018.01.031","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10139_CR29","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/ejhf.1103","volume":"20","author":"M Merlo","year":"2018","unstructured":"Merlo M, Cannat\u00e0 A, Gobbo M, Stolfo D, Elliott PM, Sinagra G (2018) Evolving concepts in dilated cardiomyopathy: evolving concepts in DCM. Eur J Heart Fail 20(2):228\u2013239. https:\/\/doi.org\/10.1002\/ejhf.1103","journal-title":"Eur J Heart Fail"},{"key":"10139_CR30","doi-asserted-by":"publisher","unstructured":"Roberts AM, Ware JS, Herman DS et al (2015) Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease. Sci Transl Med 7(270):270ra6\u2013270ra6. https:\/\/doi.org\/10.1126\/scitranslmed.3010134","DOI":"10.1126\/scitranslmed.3010134"},{"issue":"1","key":"10139_CR31","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1161\/CIRCULATIONAHA.119.039573","volume":"140","author":"CM Haggerty","year":"2019","unstructured":"Haggerty CM, Damrauer SM, Levin MG et al (2019) Genomics-first evaluation of heart disease associated with titin-truncating variants. Circulation 140(1):42\u201354. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.039573","journal-title":"Circulation"},{"issue":"4","key":"10139_CR32","doi-asserted-by":"publisher","first-page":"214","DOI":"10.2174\/157340311799960645","volume":"7","author":"M Volkova","year":"2012","unstructured":"Volkova M, Russell R (2012) Anthracycline cardiotoxicity: prevalence, pathogenesis and treatment. Curr Cardiol Rev 7(4):214\u2013220. https:\/\/doi.org\/10.2174\/157340311799960645","journal-title":"Curr Cardiol Rev"},{"issue":"10","key":"10139_CR33","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.cardfail.2011.05.008","volume":"17","author":"A George","year":"2011","unstructured":"George A, Figueredo VM (2011) Alcoholic cardiomyopathy: a review. J Card Fail 17(10):844\u2013849. https:\/\/doi.org\/10.1016\/j.cardfail.2011.05.008","journal-title":"J Card Fail"},{"issue":"33","key":"10139_CR34","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1093\/eurheartj\/eht210","volume":"34","author":"ALP Caforio","year":"2013","unstructured":"Caforio ALP, Pankuweit S, Arbustini E et al (2013) Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 34(33):2636\u20132648. https:\/\/doi.org\/10.1093\/eurheartj\/eht210","journal-title":"Eur Heart J"},{"issue":"18","key":"10139_CR35","doi-asserted-by":"publisher","first-page":"6462","DOI":"10.3390\/ijms21186462","volume":"21","author":"E Monda","year":"2020","unstructured":"Monda E, Palmiero G, Rubino M et al (2020) Molecular basis of inflammation in the pathogenesis of cardiomyopathies. Int J Mol Sci 21(18):6462. https:\/\/doi.org\/10.3390\/ijms21186462","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10139_CR36","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1161\/01.CIR.0000155616.07901.35","volume":"111","author":"U K\u00fchl","year":"2005","unstructured":"K\u00fchl U, Pauschinger M, Noutsias M et al (2005) High prevalence of viral genomes and multiple viral infections in the myocardium of adults with \u201cidiopathic\u201d left ventricular dysfunction. Circulation 111(7):887\u2013893. https:\/\/doi.org\/10.1161\/01.CIR.0000155616.07901.35","journal-title":"Circulation"},{"issue":"8925","key":"10139_CR37","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/S0140-6736(94)92339-6","volume":"344","author":"ALP Caforio","year":"1994","unstructured":"Caforio ALP, Keeling PJ, McKenna WJ et al (1994) Evidence from family studies for autoimmunity in dilated cardiomyopathy. The Lancet 344(8925):773\u2013777. https:\/\/doi.org\/10.1016\/S0140-6736(94)92339-6","journal-title":"The Lancet"},{"issue":"1","key":"10139_CR38","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1161\/CIRCULATIONAHA.106.641472","volume":"115","author":"ALP Caforio","year":"2007","unstructured":"Caforio ALP, Mahon NG, Baig MK et al (2007) Prospective familial assessment in dilated cardiomyopathy: cardiac autoantibodies predict disease development in asymptomatic relatives. Circulation 115(1):76\u201383. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.641472","journal-title":"Circulation"},{"issue":"2","key":"10139_CR39","doi-asserted-by":"publisher","first-page":"108","DOI":"10.7326\/0003-4819-143-2-200507190-00009","volume":"143","author":"NG Mahon","year":"2005","unstructured":"Mahon NG, Murphy RT, MacRae CA, Caforio ALP, Elliott PM, McKenna WJ (2005) Echocardiographic evaluation in asymptomatic relatives of patients with dilated cardiomyopathy reveals preclinical disease. Ann Intern Med 143(2):108. https:\/\/doi.org\/10.7326\/0003-4819-143-2-200507190-00009","journal-title":"Ann Intern Med"},{"key":"10139_CR40","doi-asserted-by":"publisher","unstructured":"Puntmann VO, Carerj ML, Wieters I et al (2020) Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol. Published Online 27 Jul 2020 https:\/\/doi.org\/10.1001\/jamacardio.2020.3557","DOI":"10.1001\/jamacardio.2020.3557"},{"issue":"10","key":"10139_CR41","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1016\/j.jacc.2020.06.068","volume":"76","author":"Y Sandoval","year":"2020","unstructured":"Sandoval Y, Januzzi JL, Jaffe AS (2020) Cardiac troponin for assessment of myocardial injury in COVID-19. J Am Coll Cardiol 76(10):1244\u20131258. https:\/\/doi.org\/10.1016\/j.jacc.2020.06.068","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"10139_CR42","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1001\/jama.2020.4326","volume":"323","author":"M Arentz","year":"2020","unstructured":"Arentz M, Yim E, Klaff L et al (2020) Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State. JAMA 323(16):1612. https:\/\/doi.org\/10.1001\/jama.2020.4326","journal-title":"JAMA"},{"issue":"8","key":"10139_CR43","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1093\/eurjhf\/hfq120","volume":"12","author":"K Sliwa","year":"2010","unstructured":"Sliwa K, Hilfiker-Kleiner D, Petrie MC et al (2010) Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail 12(8):767\u2013778. https:\/\/doi.org\/10.1093\/eurjhf\/hfq120","journal-title":"Eur J Heart Fail"},{"key":"10139_CR44","doi-asserted-by":"publisher","unstructured":"Endorsed by the European Society of Gynecology (ESG), the Association for European Paediatric Cardiology (AEPC), and the German Society for Gender Medicine (DGesGM), Authors\/Task Force Members, Regitz-Zagrosek V et al (2011) ESC Guidelines on the management of cardiovascular diseases during pregnancy: The Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J 32(24):3147\u20133197. https:\/\/doi.org\/10.1093\/eurheartj\/ehr218","DOI":"10.1093\/eurheartj\/ehr218"},{"issue":"35","key":"10139_CR45","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1093\/eurheartj\/ehx355","volume":"38","author":"D Hilfiker-Kleiner","year":"2017","unstructured":"Hilfiker-Kleiner D, Haghikia A, Berliner D et al (2017) Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study. Eur Heart J 38(35):2671\u20132679. https:\/\/doi.org\/10.1093\/eurheartj\/ehx355","journal-title":"Eur Heart J"},{"issue":"6","key":"10139_CR46","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1093\/eurjhf\/hft013","volume":"15","author":"KY van Spaendonck-Zwarts","year":"2013","unstructured":"van Spaendonck-Zwarts KY, van Rijsingen IAW, van den Berg MP et al (2013) Genetic analysis in 418 index patients with idiopathic dilated cardiomyopathy: overview of 10 years\u2019 experience. Eur J Heart Fail 15(6):628\u2013636. https:\/\/doi.org\/10.1093\/eurjhf\/hft013","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"10139_CR47","first-page":"316","volume":"52","author":"A Anastasakis","year":"2011","unstructured":"Anastasakis A, Sevdalis E, Papatheodorou E, Stefanadis C (2011) Anderson-Fabry disease: a cardiomyopathy that can be cured. Hell J Cardiol HJC Hell Kardiologike Epitheorese 52(4):316\u2013326","journal-title":"Hell J Cardiol HJC Hell Kardiologike Epitheorese"},{"issue":"33","key":"10139_CR48","doi-asserted-by":"publisher","first-page":"5997","DOI":"10.2174\/13816128113199990353","volume":"19","author":"A Anastasakis","year":"2013","unstructured":"Anastasakis A, Papatheodorou E, Steriotis AK (2013) Fabry disease and cardiovascular involvement. Curr Pharm Des 19(33):5997\u20136008. https:\/\/doi.org\/10.2174\/13816128113199990353","journal-title":"Curr Pharm Des"},{"issue":"2","key":"10139_CR49","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1056\/NEJM199201093260201","volume":"326","author":"VV Michels","year":"1992","unstructured":"Michels VV, Moll PP, Miller FA et al (1992) The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N Engl J Med 326(2):77\u201382. https:\/\/doi.org\/10.1056\/NEJM199201093260201","journal-title":"N Engl J Med"},{"issue":"11","key":"10139_CR50","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/j.jacc.2019.06.072","volume":"74","author":"M Gigli","year":"2019","unstructured":"Gigli M, Merlo M, Graw SL et al (2019) Genetic risk of arrhythmic phenotypes in patients with dilated cardiomyopathy. J Am Coll Cardiol 74(11):1480\u20131490. https:\/\/doi.org\/10.1016\/j.jacc.2019.06.072","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10139_CR51","doi-asserted-by":"publisher","first-page":"e570","DOI":"10.1016\/j.ejmg.2011.07.005","volume":"54","author":"G Millat","year":"2011","unstructured":"Millat G, Bouvagnet P, Chevalier P et al (2011) Clinical and mutational spectrum in a cohort of 105 unrelated patients with dilated cardiomyopathy. Eur J Med Genet 54(6):e570\u2013e575. https:\/\/doi.org\/10.1016\/j.ejmg.2011.07.005","journal-title":"Eur J Med Genet"},{"issue":"18","key":"10139_CR52","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1093\/eurheartj\/ehu301","volume":"36","author":"J Haas","year":"2015","unstructured":"Haas J, Frese KS, Peil B et al (2015) Atlas of the clinical genetics of human dilated cardiomyopathy. Eur Heart J 36(18):1123\u20131135. https:\/\/doi.org\/10.1093\/eurheartj\/ehu301","journal-title":"Eur Heart J"},{"issue":"7","key":"10139_CR53","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1056\/NEJMoa1110186","volume":"366","author":"DS Herman","year":"2012","unstructured":"Herman DS, Lam L, Taylor MRG et al (2012) Truncations of titin causing dilated cardiomyopathy. N Engl J Med 366(7):619\u2013628. https:\/\/doi.org\/10.1056\/NEJMoa1110186","journal-title":"N Engl J Med"},{"issue":"2","key":"10139_CR54","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1161\/CIRCGENETICS.111.000062","volume":"6","author":"N Norton","year":"2013","unstructured":"Norton N, Li D, Rampersaud E et al (2013) Exome sequencing and genome-wide linkage analysis in 17 families illustrate the complex contribution of TTN truncating variants to dilated cardiomyopathy. Circ Cardiovasc Genet 6(2):144\u2013153. https:\/\/doi.org\/10.1161\/CIRCGENETICS.111.000062","journal-title":"Circ Cardiovasc Genet"},{"issue":"1","key":"10139_CR55","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ahj.2008.01.026","volume":"156","author":"SB Parks","year":"2008","unstructured":"Parks SB, Kushner JD, Nauman D et al (2008) Lamin A\/C mutation analysis in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy. Am Heart J 156(1):161\u2013169. https:\/\/doi.org\/10.1016\/j.ahj.2008.01.026","journal-title":"Am Heart J"},{"issue":"5","key":"10139_CR56","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/s0735-1097(02)02954-6","volume":"41","author":"MRG Taylor","year":"2003","unstructured":"Taylor MRG, Fain PR, Sinagra G et al (2003) Natural history of dilated cardiomyopathy due to lamin A\/C gene mutations. J Am Coll Cardiol 41(5):771\u2013780. https:\/\/doi.org\/10.1016\/s0735-1097(02)02954-6","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"10139_CR57","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1016\/j.jacc.2016.08.058","volume":"68","author":"S Kumar","year":"2016","unstructured":"Kumar S, Baldinger SH, Gandjbakhch E et al (2016) Long-term arrhythmic and nonarrhythmic outcomes of lamin A\/C mutation carriers. J Am Coll Cardiol 68(21):2299\u20132307. https:\/\/doi.org\/10.1016\/j.jacc.2016.08.058","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10139_CR58","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1093\/eurjhf\/hfs191","volume":"15","author":"IAW van Rijsingen","year":"2013","unstructured":"van Rijsingen IAW, Nannenberg EA, Arbustini E et al (2013) Gender-specific differences in major cardiac events and mortality in lamin A\/C mutation carriers. Eur J Heart Fail 15(4):376\u2013384. https:\/\/doi.org\/10.1093\/eurjhf\/hfs191","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"10139_CR59","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.jacc.2011.08.078","volume":"59","author":"IAW van Rijsingen","year":"2012","unstructured":"van Rijsingen IAW, Arbustini E, Elliott PM et al (2012) Risk factors for malignant ventricular arrhythmias in lamin A\/C mutation carriers. J Am Coll Cardiol 59(5):493\u2013500. https:\/\/doi.org\/10.1016\/j.jacc.2011.08.078","journal-title":"J Am Coll Cardiol"},{"key":"10139_CR60","doi-asserted-by":"publisher","unstructured":"Priori SG, Blomstr\u00f6m-Lundqvist C, Mazzanti A et al (2015) 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the task force for the management of patients with Ventricular Arrhythmias and the prevention of sudden cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J 36(41):2793\u20132867. https:\/\/doi.org\/10.1093\/eurheartj\/ehv316","DOI":"10.1093\/eurheartj\/ehv316"},{"issue":"9","key":"10139_CR61","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/nrcardio.2013.105","volume":"10","author":"RE Hershberger","year":"2013","unstructured":"Hershberger RE, Hedges DJ, Morales A (2013) Dilated cardiomyopathy: the complexity of a diverse genetic architecture. Nat Rev Cardiol 10(9):531\u2013547. https:\/\/doi.org\/10.1038\/nrcardio.2013.105","journal-title":"Nat Rev Cardiol"},{"issue":"17","key":"10139_CR62","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1001\/jama.1996.03530410049032","volume":"275","author":"L Politano","year":"1996","unstructured":"Politano L, Nigro V, Nigro G et al (1996) Development of cardiomyopathy in female carriers of Duchenne and Becker muscular dystrophies. JAMA 275(17):1335\u20131338","journal-title":"JAMA"},{"issue":"12","key":"10139_CR63","doi-asserted-by":"publisher","first-page":"3168","DOI":"10.1161\/01.CIR.94.12.3168","volume":"94","author":"P Melacini","year":"1996","unstructured":"Melacini P, Fanin M, Danieli GA et al (1996) Myocardial involvement is very frequent among patients affected with subclinical Becker\u2019s muscular dystrophy. Circulation 94(12):3168\u20133175. https:\/\/doi.org\/10.1161\/01.CIR.94.12.3168","journal-title":"Circulation"},{"issue":"22","key":"10139_CR64","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1016\/j.jacc.2016.09.927","volume":"68","author":"MF Ortiz-Genga","year":"2016","unstructured":"Ortiz-Genga MF, Cuenca S, Dal Ferro M et al (2016) Truncating FLNC mutations are associated with high-risk dilated and arrhythmogenic cardiomyopathies. J Am Coll Cardiol 68(22):2440\u20132451. https:\/\/doi.org\/10.1016\/j.jacc.2016.09.927","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10139_CR65","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1136\/jmedgenet-2014-102591","volume":"51","author":"F Brun","year":"2014","unstructured":"Brun F, Barnes CV, Sinagra G et al (2014) Titin and desmosomal genes in the natural history of arrhythmogenic right ventricular cardiomyopathy. J Med Genet 51(10):669\u2013676. https:\/\/doi.org\/10.1136\/jmedgenet-2014-102591","journal-title":"J Med Genet"},{"issue":"10","key":"10139_CR66","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.jacc.2009.05.038","volume":"54","author":"KM Brauch","year":"2009","unstructured":"Brauch KM, Karst ML, Herron KJ et al (2009) Mutations in ribonucleic acid binding protein gene cause familial dilated cardiomyopathy. J Am Coll Cardiol 54(10):930\u2013941. https:\/\/doi.org\/10.1016\/j.jacc.2009.05.038","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10139_CR67","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.ajhg.2011.01.016","volume":"88","author":"N Norton","year":"2011","unstructured":"Norton N, Li D, Rieder MJ et al (2011) Genome-wide studies of copy number variation and exome sequencing identify rare variants in BAG3 as a cause of dilated cardiomyopathy. Am J Hum Genet 88(3):273\u2013282. https:\/\/doi.org\/10.1016\/j.ajhg.2011.01.016","journal-title":"Am J Hum Genet"},{"key":"10139_CR68","doi-asserted-by":"publisher","unstructured":"Rapezzi C, Arbustini E, Caforio ALP et al (2013) Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases. Eur Heart J 34(19):1448\u20131458. https:\/\/doi.org\/10.1093\/eurheartj\/ehs397","DOI":"10.1093\/eurheartj\/ehs397"},{"issue":"22","key":"10139_CR69","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1093\/eurheartj\/ehq271","volume":"31","author":"P Charron","year":"2010","unstructured":"Charron P, Arad M, Arbustini E et al (2010) Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 31(22):2715\u20132726. https:\/\/doi.org\/10.1093\/eurheartj\/ehq271","journal-title":"Eur Heart J"},{"issue":"11","key":"10139_CR70","doi-asserted-by":"publisher","first-page":"e301","DOI":"10.1016\/j.hrthm.2019.05.007","volume":"16","author":"JA Towbin","year":"2019","unstructured":"Towbin JA, McKenna WJ, Abrams DJ et al (2019) 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy. Heart Rhythm 16(11):e301\u2013e372. https:\/\/doi.org\/10.1016\/j.hrthm.2019.05.007","journal-title":"Heart Rhythm"},{"issue":"9","key":"10139_CR71","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1001\/jama.2013.1363","volume":"309","author":"A Gulati","year":"2013","unstructured":"Gulati A, Jabbour A, Ismail TF et al (2013) Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA 309(9):896. https:\/\/doi.org\/10.1001\/jama.2013.1363","journal-title":"JAMA"},{"issue":"1","key":"10139_CR72","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ijcard.2010.11.005","volume":"157","author":"PG Masci","year":"2012","unstructured":"Masci PG, Barison A, Aquaro GD et al (2012) Myocardial delayed enhancement in paucisymptomatic nonischemic dilated cardiomyopathy. Int J Cardiol 157(1):43\u201347. https:\/\/doi.org\/10.1016\/j.ijcard.2010.11.005","journal-title":"Int J Cardiol"},{"issue":"3","key":"10139_CR73","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1161\/CIRCHEARTFAILURE.113.000996","volume":"7","author":"PG Masci","year":"2014","unstructured":"Masci PG, Doulaptsis C, Bertella E et al (2014) Incremental prognostic value of myocardial fibrosis in patients with non\u2013ischemic cardiomyopathy without congestive heart failure. Circ Heart Fail 7(3):448\u2013456. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.113.000996","journal-title":"Circ Heart Fail"},{"issue":"1","key":"10139_CR74","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11897-010-0005-9","volume":"7","author":"RV Shah","year":"2010","unstructured":"Shah RV, Januzzi JL (2010) ST2: A novel remodeling biomarker in acute and chronic heart failure. Curr Heart Fail Rep 7(1):9\u201314. https:\/\/doi.org\/10.1007\/s11897-010-0005-9","journal-title":"Curr Heart Fail Rep"},{"issue":"18","key":"10139_CR75","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1016\/j.jacc.2008.07.042","volume":"52","author":"SU Rehman","year":"2008","unstructured":"Rehman SU, Mueller T, Januzzi JL (2008) Characteristics of the novel interleukin family biomarker ST2 in patients with acute heart failure. J Am Coll Cardiol 52(18):1458\u20131465. https:\/\/doi.org\/10.1016\/j.jacc.2008.07.042","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10139_CR76","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S0022-0736(05)80270-5","volume":"27","author":"Y Momiyama","year":"1994","unstructured":"Momiyama Y, Mitamura H, Kimura M (1994) ECG characteristics of dilated cardiomyopathy. J Electrocardiol 27(4):323\u2013328. https:\/\/doi.org\/10.1016\/S0022-0736(05)80270-5","journal-title":"J Electrocardiol"},{"issue":"7","key":"10139_CR77","doi-asserted-by":"publisher","first-page":"450","DOI":"10.2459\/JCM.0000000000000804","volume":"20","author":"M Merlo","year":"2019","unstructured":"Merlo M, Zaffalon D, Stolfo D et al (2019) ECG in dilated cardiomyopathy: specific findings and long-term prognostic significance. J Cardiovasc Med 20(7):450\u2013458. https:\/\/doi.org\/10.2459\/JCM.0000000000000804","journal-title":"J Cardiovasc Med"},{"issue":"23","key":"10139_CR78","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.1161\/01.CIR.0000100721.52503.85","volume":"108","author":"W Grimm","year":"2003","unstructured":"Grimm W, Christ M, Bach J, M\u00fcller H-H, Maisch B (2003) Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study. Circulation 108(23):2883\u20132891. https:\/\/doi.org\/10.1161\/01.CIR.0000100721.52503.85","journal-title":"Circulation"},{"issue":"2","key":"10139_CR79","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1093\/europace\/euy179","volume":"21","author":"G Finocchiaro","year":"2019","unstructured":"Finocchiaro G, Papadakis M, Dhutia H et al (2019) Electrocardiographic differentiation between \u2018benign T-wave inversion\u2019 and arrhythmogenic right ventricular cardiomyopathy. EP Eur 21(2):332\u2013338. https:\/\/doi.org\/10.1093\/europace\/euy179","journal-title":"EP Eur"},{"issue":"3\u20134","key":"10139_CR80","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3121\/cmr.2010.908","volume":"8","author":"A Aleksova","year":"2010","unstructured":"Aleksova A, Merlo M, Zecchin M et al (2010) Impact of atrial fibrillation on outcome of patients with idiopathic dilated cardiomyopathy: data from the Heart Muscle Disease Registry of Trieste. Clin Med Res 8(3\u20134):142\u2013149. https:\/\/doi.org\/10.3121\/cmr.2010.908","journal-title":"Clin Med Res"},{"issue":"10","key":"10139_CR81","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1093\/europace\/euu016","volume":"16","author":"A Aleksova","year":"2014","unstructured":"Aleksova A, Carriere C, Zecchin M et al (2014) New-onset left bundle branch block independently predicts long-term mortality in patients with idiopathic dilated cardiomyopathy: data from the Trieste Heart Muscle Disease Registry. Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol 16(10):1450\u20131459. https:\/\/doi.org\/10.1093\/europace\/euu016","journal-title":"Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol"},{"issue":"12","key":"10139_CR82","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1136\/bjsports-2017-098528","volume":"54","author":"A Malhotra","year":"2020","unstructured":"Malhotra A, Dhutia H, Yeo T-J et al (2020) Accuracy of the 2017 international recommendations for clinicians who interpret adolescent athletes\u2019 ECGs: a cohort study of 11 168 British white and black soccer players. Br J Sports Med 54(12):739\u2013745. https:\/\/doi.org\/10.1136\/bjsports-2017-098528","journal-title":"Br J Sports Med"},{"issue":"16","key":"10139_CR83","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1093\/eurheartj\/ehw631","volume":"39","author":"S Sharma","year":"2018","unstructured":"Sharma S, Drezner JA, Baggish A et al (2018) International recommendations for electrocardiographic interpretation in athletes. Eur Heart J 39(16):1466\u20131480. https:\/\/doi.org\/10.1093\/eurheartj\/ehw631","journal-title":"Eur Heart J"},{"key":"10139_CR84","doi-asserted-by":"publisher","unstructured":"Puggia I, Merlo M, Barbati G et al (2016) Natural history of dilated cardiomyopathy in children. J Am Heart Assoc 5(7). https:\/\/doi.org\/10.1161\/JAHA.116.003450","DOI":"10.1161\/JAHA.116.003450"},{"issue":"5","key":"10139_CR85","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jacep.2016.05.002","volume":"2","author":"P Losurdo","year":"2016","unstructured":"Losurdo P, Stolfo D, Merlo M et al (2016) Early arrhythmic events in idiopathic dilated cardiomyopathy. JACC Clin Electrophysiol 2(5):535\u2013543. https:\/\/doi.org\/10.1016\/j.jacep.2016.05.002","journal-title":"JACC Clin Electrophysiol"},{"issue":"3","key":"10139_CR86","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/0735-1097(93)90195-7","volume":"22","author":"B Pinamonti","year":"1993","unstructured":"Pinamonti B, Di Lenarda A, Sinagra G, Camerini F (1993) Restrictive left ventricular filling pattern in dilated cardiomyopathy assessed by Doppler echocardiography: clinical, echocardiographic and hemodynamic correlations and prognostic implications. J Am Coll Cardiol 22(3):808\u2013815. https:\/\/doi.org\/10.1016\/0735-1097(93)90195-7","journal-title":"J Am Coll Cardiol"},{"key":"10139_CR87","doi-asserted-by":"publisher","unstructured":"Rossi A, Dini FL, Faggiano P et al (2011) Independent prognostic value of functional mitral regurgitation in patients with heart failure. a quantitative analysis of 1256 patients with ischaemic and non-ischaemic dilated cardiomyopathy. Heart 97(20):1675\u20131680. https:\/\/doi.org\/10.1136\/hrt.2011.225789","DOI":"10.1136\/hrt.2011.225789"},{"issue":"13","key":"10139_CR88","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1016\/j.jacc.2010.11.030","volume":"57","author":"M Merlo","year":"2011","unstructured":"Merlo M, Pyxaras SA, Pinamonti B, Barbati G, Di Lenarda A, Sinagra G (2011) Prevalence and prognostic significance of left ventricular reverse remodeling in dilated cardiomyopathy receiving tailored medical treatment. J Am Coll Cardiol 57(13):1468\u20131476. https:\/\/doi.org\/10.1016\/j.jacc.2010.11.030","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10139_CR89","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1093\/ejechocard\/jep052","volume":"10","author":"S Puwanant","year":"2009","unstructured":"Puwanant S, Priester TC, Mookadam F, Bruce CJ, Redfield MM, Chandrasekaran K (2009) Right ventricular function in patients with preserved and reduced ejection fraction heart failure. Eur J Echocardiogr 10(6):733\u2013737. https:\/\/doi.org\/10.1093\/ejechocard\/jep052","journal-title":"Eur J Echocardiogr"},{"issue":"2","key":"10139_CR90","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.jcmg.2019.02.032","volume":"13","author":"JAJ Verdonschot","year":"2020","unstructured":"Verdonschot JAJ, Merken JJ, Brunner-La Rocca H-P et al (2020) Value of speckle tracking\u2013based deformation analysis in screening relatives of patients with asymptomatic dilated cardiomyopathy. JACC Cardiovasc Imaging 13(2):549\u2013558. https:\/\/doi.org\/10.1016\/j.jcmg.2019.02.032","journal-title":"JACC Cardiovasc Imaging"},{"issue":"10","key":"10139_CR91","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/j.jcmg.2017.10.024","volume":"11","author":"S Romano","year":"2018","unstructured":"Romano S, Judd RM, Kim RJ et al (2018) Feature-tracking global longitudinal strain predicts death in a multicenter population of patients with ischemic and nonischemic dilated cardiomyopathy incremental to ejection fraction and late gadolinium enhancement. JACC Cardiovasc Imaging 11(10):1419\u20131429. https:\/\/doi.org\/10.1016\/j.jcmg.2017.10.024","journal-title":"JACC Cardiovasc Imaging"},{"issue":"5","key":"10139_CR92","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1161\/CIRCULATIONAHA.104.532234","volume":"112","author":"M Norman","year":"2005","unstructured":"Norman M, Simpson M, Mogensen J et al (2005) Novel mutation in desmoplakin causes arrhythmogenic left ventricular cardiomyopathy. Circulation 112(5):636\u2013642. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.104.532234","journal-title":"Circulation"},{"issue":"7","key":"10139_CR93","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.hrthm.2017.03.034","volume":"14","author":"S Sepehrkhouy","year":"2017","unstructured":"Sepehrkhouy S, Gho JMIH, van Es R et al (2017) Distinct fibrosis pattern in desmosomal and phospholamban mutation carriers in hereditary cardiomyopathies. Heart Rhythm 14(7):1024\u20131032. https:\/\/doi.org\/10.1016\/j.hrthm.2017.03.034","journal-title":"Heart Rhythm"},{"issue":"14","key":"10139_CR94","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1136\/heartjnl-2019-316147","volume":"106","author":"LM Millar","year":"2020","unstructured":"Millar LM, Fanton Z, Finocchiaro G et al (2020) Differentiation between athlete\u2019s heart and dilated cardiomyopathy in athletic individuals. Heart 106(14):1059\u20131065. https:\/\/doi.org\/10.1136\/heartjnl-2019-316147","journal-title":"Heart"},{"issue":"1","key":"10139_CR95","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12968-020-0598-4","volume":"22","author":"T-T Le","year":"2020","unstructured":"Le T-T, Bryant JA, Ang BWY et al (2020) The application of exercise stress cardiovascular magnetic resonance in patients with suspected dilated cardiomyopathy. J Cardiovasc Magn Reson 22(1):10. https:\/\/doi.org\/10.1186\/s12968-020-0598-4","journal-title":"J Cardiovasc Magn Reson"},{"issue":"6","key":"10139_CR96","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1097\/01.hjr.0000238393.96975.32","volume":"13","author":"A Pelliccia","year":"2006","unstructured":"Pelliccia A, Corrado D, Bj\u00f8rnstad HH et al (2006) Recommendations for participation in competitive sport and leisure-time physical activity in individuals with cardiomyopathies, myocarditis and pericarditis. Eur J Cardiovasc Prev Rehabil 13(6):876\u2013885. https:\/\/doi.org\/10.1097\/01.hjr.0000238393.96975.32","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10139_CR97","doi-asserted-by":"publisher","unstructured":"Hey TM, Rasmussen TB, Madsen T et al (2020) Clinical and genetic investigations of 109 index patients with dilated cardiomyopathy and 445 of their relatives. Circ Heart Fail 13(10). https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.119.006701","DOI":"10.1161\/CIRCHEARTFAILURE.119.006701"},{"issue":"2","key":"10139_CR98","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1056\/NEJMoa052948","volume":"355","author":"DS Lee","year":"2006","unstructured":"Lee DS, Pencina MJ, Benjamin EJ et al (2006) Association of parental heart failure with risk of heart failure in offspring. N Engl J Med 355(2):138\u2013147. https:\/\/doi.org\/10.1056\/NEJMoa052948","journal-title":"N Engl J Med"},{"issue":"5","key":"10139_CR99","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med Off J Am Coll Med Genet 17(5):405\u2013424. https:\/\/doi.org\/10.1038\/gim.2015.30","journal-title":"Genet Med Off J Am Coll Med Genet"},{"issue":"17","key":"10139_CR100","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1016\/j.jacc.2017.02.046","volume":"69","author":"N Lahrouchi","year":"2017","unstructured":"Lahrouchi N, Raju H, Lodder EM et al (2017) Utility of post-mortem genetic testing in cases of sudden arrhythmic death syndrome. J Am Coll Cardiol 69(17):2134\u20132145. https:\/\/doi.org\/10.1016\/j.jacc.2017.02.046","journal-title":"J Am Coll Cardiol"},{"key":"10139_CR101","doi-asserted-by":"publisher","unstructured":"Al-Khatib SM, Stevenson WG, Ackerman MJ et al (2018) 2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation 138(13). https:\/\/doi.org\/10.1161\/CIR.0000000000000549","DOI":"10.1161\/CIR.0000000000000549"},{"issue":"6","key":"10139_CR102","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/S0735-1097(97)00355-0","volume":"30","author":"JJM de Vreede-Swagemakers","year":"1997","unstructured":"de Vreede-Swagemakers JJM, Gorgels APM, Dubois-Arbouw WI et al (1997) Out-of-hospital cardiac arrest in the 1990s: a population-based study in the Maastricht area on incidence, characteristics and survival. J Am Coll Cardiol 30(6):1500\u20131505. https:\/\/doi.org\/10.1016\/S0735-1097(97)00355-0","journal-title":"J Am Coll Cardiol"},{"key":"10139_CR103","doi-asserted-by":"publisher","unstructured":"Gorgels A (2003) Out-of-hospital cardiac arrest-the relevance of heart failure. The Maastricht Circulatory Arrest Registry. Eur Heart J 24(13):1204\u20131209. https:\/\/doi.org\/10.1016\/S0195-668X(03)00191-X","DOI":"10.1016\/S0195-668X(03)00191-X"},{"issue":"2","key":"10139_CR104","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1161\/CIRCIMAGING.113.001144","volume":"7","author":"S Kuruvilla","year":"2014","unstructured":"Kuruvilla S, Adenaw N, Katwal AB, Lipinski MJ, Kramer CM, Salerno M (2014) Late gadolinium enhancement on cardiac magnetic resonance predicts adverse cardiovascular outcomes in nonischemic cardiomyopathy: a systematic review and meta-analysis. Circ Cardiovasc Imaging 7(2):250\u2013258. https:\/\/doi.org\/10.1161\/CIRCIMAGING.113.001144","journal-title":"Circ Cardiovasc Imaging"},{"issue":"1","key":"10139_CR105","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jchf.2016.09.017","volume":"5","author":"A Di Marco","year":"2017","unstructured":"Di Marco A, Anguera I, Schmitt M et al (2017) Late gadolinium enhancement and the risk for ventricular arrhythmias or sudden death in dilated cardiomyopathy. JACC Heart Fail 5(1):28\u201338. https:\/\/doi.org\/10.1016\/j.jchf.2016.09.017","journal-title":"JACC Heart Fail"},{"issue":"5","key":"10139_CR106","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1161\/CIRCIMAGING.113.000438","volume":"6","author":"PG Masci","year":"2013","unstructured":"Masci PG, Schuurman R, Andrea B et al (2013) Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study. Circ Cardiovasc Imaging 6(5):790\u2013799. https:\/\/doi.org\/10.1161\/CIRCIMAGING.113.000438","journal-title":"Circ Cardiovasc Imaging"},{"issue":"12","key":"10139_CR107","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1093\/europace\/euu128","volume":"16","author":"JM L\u00f3pez-Ayala","year":"2014","unstructured":"L\u00f3pez-Ayala JM, G\u00f3mez-Milan\u00e9s I, S\u00e1nchez Mu\u00f1oz JJ et al (2014) Desmoplakin truncations and arrhythmogenic left ventricular cardiomyopathy: characterizing a phenotype. EP Eur 16(12):1838\u20131846. https:\/\/doi.org\/10.1093\/europace\/euu128","journal-title":"EP Eur"},{"issue":"14","key":"10139_CR108","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1093\/eurheartj\/ehu509","volume":"36","author":"A Bhonsale","year":"2015","unstructured":"Bhonsale A, Groeneweg JA, James CA et al (2015) Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia\/cardiomyopathy-associated mutation carriers. Eur Heart J 36(14):847\u2013855. https:\/\/doi.org\/10.1093\/eurheartj\/ehu509","journal-title":"Eur Heart J"},{"issue":"2","key":"10139_CR109","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1056\/NEJMc052632","volume":"354","author":"C Meune","year":"2006","unstructured":"Meune C, Van Berlo JH, Anselme F, Bonne G, Pinto YM, Duboc D (2006) Primary prevention of sudden death in patients with lamin A\/C gene mutations. N Engl J Med 354(2):209\u2013210. https:\/\/doi.org\/10.1056\/NEJMc052632","journal-title":"N Engl J Med"},{"key":"10139_CR110","doi-asserted-by":"publisher","unstructured":"Hodgkinson K, Connors S, Merner N et al (2013) The natural history of a genetic subtype of arrhythmogenic right ventricular cardiomyopathy caused by a p.S358L mutation in TMEM43: natural history of a genetic subtype of ARVC. Clin Genet 83(4):321\u2013331. https:\/\/doi.org\/10.1111\/j.1399-0004.2012.01919.x","DOI":"10.1111\/j.1399-0004.2012.01919.x"},{"issue":"4","key":"10139_CR111","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1161\/CIRCGENETICS.113.000374","volume":"7","author":"IAW van Rijsingen","year":"2014","unstructured":"van Rijsingen IAW, van der Zwaag PA, Groeneweg JA et al (2014) Outcome in phospholamban R14del carriers: results of a large multicentre cohort study. Circ Cardiovasc Genet 7(4):455\u2013465. https:\/\/doi.org\/10.1161\/CIRCGENETICS.113.000374","journal-title":"Circ Cardiovasc Genet"},{"issue":"20","key":"10139_CR112","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1016\/j.jacc.2018.08.2181","volume":"72","author":"F Dom\u00ednguez","year":"2018","unstructured":"Dom\u00ednguez F, Cuenca S, Bili\u0144ska Z et al (2018) Dilated cardiomyopathy due to BLC2-sssociated athanogene 3 (BAG3) mutations. J Am Coll Cardiol 72(20):2471\u20132481. https:\/\/doi.org\/10.1016\/j.jacc.2018.08.2181","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10139_CR113","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.nmd.2010.05.004","volume":"20","author":"Z Odgerel","year":"2010","unstructured":"Odgerel Z, Sarkozy A, Lee H-S et al (2010) Inheritance patterns and phenotypic features of myofibrillar myopathy associated with a BAG3 mutation. Neuromuscul Disord 20(7):438\u2013442. https:\/\/doi.org\/10.1016\/j.nmd.2010.05.004","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"10139_CR114","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/ana.21553","volume":"65","author":"D Selcen","year":"2008","unstructured":"Selcen D, Muntoni F, Burton BK et al (2008) Mutation in BAG3 causes severe dominant childhood muscular dystrophy. Ann Neurol 65(1):83\u201389. https:\/\/doi.org\/10.1002\/ana.21553","journal-title":"Ann Neurol"},{"issue":"2","key":"10139_CR115","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1086\/431959","volume":"77","author":"M Vorgerd","year":"2005","unstructured":"Vorgerd M, van der Ven PFM, Bruchertseifer V et al (2005) A mutation in the dimerization domain of filamin C causes a novel type of autosomal dominant myofibrillar myopathy. Am J Hum Genet 77(2):297\u2013304. https:\/\/doi.org\/10.1086\/431959","journal-title":"Am J Hum Genet"},{"issue":"4","key":"10139_CR116","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.ajhg.2008.01.010","volume":"82","author":"ND Merner","year":"2008","unstructured":"Merner ND, Hodgkinson KA, Haywood AFM et al (2008) Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene. Am J Hum Genet 82(4):809\u2013821. https:\/\/doi.org\/10.1016\/j.ajhg.2008.01.010","journal-title":"Am J Hum Genet"},{"issue":"15","key":"10139_CR117","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1161\/CIRCULATIONAHA.118.037230","volume":"139","author":"C Miles","year":"2019","unstructured":"Miles C, Finocchiaro G, Papadakis M et al (2019) Sudden death and left ventricular involvement in arrhythmogenic cardiomyopathy. Circulation 139(15):1786\u20131797. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.037230","journal-title":"Circulation"},{"issue":"35","key":"10139_CR118","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1093\/eurheartj\/ehz260","volume":"40","author":"KA Gatzoulis","year":"2019","unstructured":"Gatzoulis KA, Tsiachris D, Arsenos P et al (2019) Arrhythmic risk stratification in post-myocardial infarction patients with preserved ejection fraction: the PRESERVE EF study. Eur Heart J 40(35):2940\u20132949. https:\/\/doi.org\/10.1093\/eurheartj\/ehz260","journal-title":"Eur Heart J"},{"key":"10139_CR119","doi-asserted-by":"publisher","unstructured":"Gatzoulis KA, Dilaveris P, Arsenos P et al (2020) Arrhythmic risk stratification in nonischemic dilated cardiomyopathy: The ReCONSIDER study design - a two-step, multifactorial, electrophysiology-inclusive approach. Hell J Cardiol HJC Hell Kardiologike Epitheorese. Published Online 21 Apr 2020 https:\/\/doi.org\/10.1016\/j.hjc.2020.03.008","DOI":"10.1016\/j.hjc.2020.03.008"},{"key":"10139_CR120","doi-asserted-by":"publisher","unstructured":"Pelliccia A, Sharma S, Gati S et al (2020) 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease. Eur Heart J. Published online 29 Aug 2020:ehaa605. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa605","DOI":"10.1093\/eurheartj\/ehaa605"},{"issue":"5","key":"10139_CR121","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.hjc.2018.05.008","volume":"59","author":"A Bakalakos","year":"2018","unstructured":"Bakalakos A, Ritsatos K, Anastasakis A (2018) Current perspectives on the diagnosis and management of dilated cardiomyopathy beyond heart failure: a Cardiomyopathy Clinic Doctor\u2019s point of view. Hellenic J Cardiol 59(5):254\u2013261. https:\/\/doi.org\/10.1016\/j.hjc.2018.05.008","journal-title":"Hellenic J Cardiol"},{"issue":"1","key":"10139_CR122","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1752-8062.2008.00017.x","volume":"1","author":"RE Hershberger","year":"2008","unstructured":"Hershberger RE, Parks SB, Kushner JD et al (2008) Coding sequence mutations identified in MYH7, TNNT2, SCN5A, CSRP3, LBD3, and TCAP from 313 patients with familial or idiopathic dilated cardiomyopathy. Clin Transl Sci 1(1):21\u201326. https:\/\/doi.org\/10.1111\/j.1752-8062.2008.00017.x","journal-title":"Clin Transl Sci"},{"issue":"2","key":"10139_CR123","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.jacc.2012.02.052","volume":"60","author":"G Laurent","year":"2012","unstructured":"Laurent G, Saal S, Amarouch MY et al (2012) Multifocal ectopic Purkinje-related premature contractions. J Am Coll Cardiol 60(2):144\u2013156. https:\/\/doi.org\/10.1016\/j.jacc.2012.02.052","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"10139_CR124","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1016\/j.jacc.2010.09.084","volume":"57","author":"WP McNair","year":"2011","unstructured":"McNair WP, Sinagra G, Taylor MRG et al (2011) SCN5A mutations associate with arrhythmic dilated cardiomyopathy and commonly localize to the voltage-sensing mechanism. J Am Coll Cardiol 57(21):2160\u20132168. https:\/\/doi.org\/10.1016\/j.jacc.2010.09.084","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"10139_CR125","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1016\/j.jacc.2012.05.050","volume":"60","author":"SA Mann","year":"2012","unstructured":"Mann SA, Castro ML, Ohanian M et al (2012) R222Q SCN5A mutation is associated with reversible ventricular ectopy and dilated cardiomyopathy. J Am Coll Cardiol 60(16):1566\u20131573. https:\/\/doi.org\/10.1016\/j.jacc.2012.05.050","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10139_CR126","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12881-018-0599-4","volume":"19","author":"J Zakrzewska-Koperska","year":"2018","unstructured":"Zakrzewska-Koperska J, Franaszczyk M, Bili\u0144ska Z et al (2018) Rapid and effective response of the R222Q SCN5A to quinidine treatment in a patient with Purkinje-related ventricular arrhythmia and familial dilated cardiomyopathy: a case report. BMC Med Genet 19(1):94. https:\/\/doi.org\/10.1186\/s12881-018-0599-4","journal-title":"BMC Med Genet"},{"issue":"19","key":"10139_CR127","doi-asserted-by":"publisher","first-page":"4325","DOI":"10.1093\/hmg\/dds265","volume":"21","author":"A Muchir","year":"2012","unstructured":"Muchir A, Wu W, Choi JC et al (2012) Abnormal p38 mitogen-activated protein kinase signaling in dilated cardiomyopathy caused by lamin A\/C gene mutation. Hum Mol Genet 21(19):4325\u20134333. https:\/\/doi.org\/10.1093\/hmg\/dds265","journal-title":"Hum Mol Genet"},{"issue":"4","key":"10139_CR128","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/nrcardio.2017.190","volume":"15","author":"JS Ware","year":"2018","unstructured":"Ware JS, Cook SA (2018) Role of titin in cardiomyopathy: from DNA variants to patient stratification. Nat Rev Cardiol 15(4):241\u2013252. https:\/\/doi.org\/10.1038\/nrcardio.2017.190","journal-title":"Nat Rev Cardiol"},{"issue":"10","key":"10139_CR129","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1093\/eurheartj\/ehx808","volume":"39","author":"JAJ Verdonschot","year":"2018","unstructured":"Verdonschot JAJ, Hazebroek MR, Derks KWJ et al (2018) Titin cardiomyopathy leads to altered mitochondrial energetics, increased fibrosis and long-term life-threatening arrhythmias. Eur Heart J 39(10):864\u2013873. https:\/\/doi.org\/10.1093\/eurheartj\/ehx808","journal-title":"Eur Heart J"},{"issue":"23","key":"10139_CR130","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1161\/CIRCULATIONAHA.117.032273","volume":"138","author":"N Ma","year":"2018","unstructured":"Ma N, Zhang JZ, Itzhaki I et al (2018) Determining the pathogenicity of a genomic variant of uncertain significance using CRISPR\/Cas9 and human-induced pluripotent stem cells. Circulation 138(23):2666\u20132681. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.032273","journal-title":"Circulation"},{"issue":"8","key":"10139_CR131","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1161\/CIRCRESAHA.117.310996","volume":"121","author":"M El Refaey","year":"2017","unstructured":"El Refaey M, Xu L, Gao Y et al (2017) In vivo genome editing restores dystrophin expression and cardiac function in dystrophic mice. Circ Res 121(8):923\u2013929. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.310996","journal-title":"Circ Res"},{"issue":"14","key":"10139_CR132","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1093\/cvr\/cvy208","volume":"114","author":"A van Mil","year":"2018","unstructured":"van Mil A, Balk GM, Neef K et al (2018) Modelling inherited cardiac disease using human induced pluripotent stem cell-derived cardiomyocytes: progress, pitfalls, and potential. Cardiovasc Res 114(14):1828\u20131842. https:\/\/doi.org\/10.1093\/cvr\/cvy208","journal-title":"Cardiovasc Res"},{"issue":"7","key":"10139_CR133","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1093\/hmg\/dds556","volume":"22","author":"H-F Tse","year":"2013","unstructured":"Tse H-F, Ho JCY, Choi S-W et al (2013) Patient-specific induced-pluripotent stem cells-derived cardiomyocytes recapitulate the pathogenic phenotypes of dilated cardiomyopathy due to a novel DES mutation identified by whole exome sequencing. Hum Mol Genet 22(7):1395\u20131403. https:\/\/doi.org\/10.1093\/hmg\/dds556","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10139_CR134","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.stem.2015.04.020","volume":"17","author":"H Wu","year":"2015","unstructured":"Wu H, Lee J, Vincent LG et al (2015) Epigenetic regulation of phosphodiesterases 2A and 3A underlies compromised \u03b2-adrenergic signaling in an iPSC model of dilated cardiomyopathy. Cell Stem Cell 17(1):89\u2013100. https:\/\/doi.org\/10.1016\/j.stem.2015.04.020","journal-title":"Cell Stem Cell"},{"key":"10139_CR135","doi-asserted-by":"publisher","unstructured":"Sun N, Yazawa M, Liu J et al (2012) Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy. Sci Transl Med 4(130):130ra47. https:\/\/doi.org\/10.1126\/scitranslmed.3003552","DOI":"10.1126\/scitranslmed.3003552"},{"key":"10139_CR136","doi-asserted-by":"publisher","first-page":"6955","DOI":"10.1038\/ncomms7955","volume":"6","author":"I Karakikes","year":"2015","unstructured":"Karakikes I, Stillitano F, Nonnenmacher M et al (2015) Correction of human phospholamban R14del mutation associated with cardiomyopathy using targeted nucleases and combination therapy. Nat Commun 6:6955. https:\/\/doi.org\/10.1038\/ncomms7955","journal-title":"Nat Commun"},{"issue":"3","key":"10139_CR137","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/cts.12393","volume":"9","author":"SP Wyles","year":"2016","unstructured":"Wyles SP, Hrstka SC, Reyes S, Terzic A, Olson TM, Nelson TJ (2016) Pharmacological modulation of calcium homeostasis in familial dilated cardiomyopathy: an in vitro analysis from an RBM20 patient-derived iPSC Model. Clin Transl Sci 9(3):158\u2013167. https:\/\/doi.org\/10.1111\/cts.12393","journal-title":"Clin Transl Sci"},{"key":"10139_CR138","doi-asserted-by":"publisher","unstructured":"Hinson JT, Chopra A, Nafissi N et al (2015) Heart Disease. Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy. Science 349(6251):982\u2013986. https:\/\/doi.org\/10.1126\/science.aaa5458","DOI":"10.1126\/science.aaa5458"},{"key":"10139_CR139","doi-asserted-by":"publisher","unstructured":"Judge LM, Perez-Bermejo JA, Truong A et al (2017) A BAG3 chaperone complex maintains cardiomyocyte function during proteotoxic stress. JCI Insight 2(14). https:\/\/doi.org\/10.1172\/jci.insight.94623","DOI":"10.1172\/jci.insight.94623"},{"issue":"43","key":"10139_CR140","doi-asserted-by":"publisher","first-page":"3282","DOI":"10.1093\/eurheartj\/ehw307","volume":"37","author":"F Stillitano","year":"2016","unstructured":"Stillitano F, Turnbull IC, Karakikes I et al (2016) Genomic correction of familial cardiomyopathy in human engineered cardiac tissues. Eur Heart J 37(43):3282\u20133284. https:\/\/doi.org\/10.1093\/eurheartj\/ehw307","journal-title":"Eur Heart J"},{"key":"10139_CR141","doi-asserted-by":"publisher","unstructured":"For the ClinGen Cardiovascular Clinical Domain Working Group, Kelly MA, Caleshu C et al (2018) Adaptation and validation of the ACMG\/AMP variant classification framework for MYH7-associated inherited cardiomyopathies: recommendations by ClinGen\u2019s Inherited Cardiomyopathy Expert Panel. Genet Med 20(3):351\u2013359. https:\/\/doi.org\/10.1038\/gim.2017.218","DOI":"10.1038\/gim.2017.218"},{"issue":"7","key":"10139_CR142","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1056\/NEJMsa1507092","volume":"375","author":"AK Manrai","year":"2016","unstructured":"Manrai AK, Funke BH, Rehm HL et al (2016) Genetic misdiagnoses and the potential for health disparities. N Engl J Med 375(7):655\u2013665. https:\/\/doi.org\/10.1056\/NEJMsa1507092","journal-title":"N Engl J Med"},{"issue":"5","key":"10139_CR143","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.amjcard.2011.10.033","volume":"109","author":"M Zecchin","year":"2012","unstructured":"Zecchin M, Merlo M, Pivetta A et al (2012) How can optimization of medical treatment avoid unnecessary implantable cardioverter-defibrillator implantations in patients with idiopathic dilated cardiomyopathy presenting with \u201cSCD-HeFT Criteria?\u201d Am J Cardiol 109(5):729\u2013735. https:\/\/doi.org\/10.1016\/j.amjcard.2011.10.033","journal-title":"Am J Cardiol"},{"key":"10139_CR144","doi-asserted-by":"publisher","unstructured":"Sinagra G, Merlo M, Pinamonti B (Ed.) (2019) Dilated cardiomyopathy: from genetics to clinical management. Springer International Publishing. https:\/\/doi.org\/10.1007\/978-3-030-13864-6","DOI":"10.1007\/978-3-030-13864-6"},{"key":"10139_CR145","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.ijcard.2015.11.099","volume":"203","author":"I Ruiz-Zamora","year":"2016","unstructured":"Ruiz-Zamora I, Rodriguez-Capitan J, Guerrero-Molina A et al (2016) Incidence and prognosis implications of long term left ventricular reverse remodeling in patients with dilated cardiomyopathy. Int J Cardiol 203:1114\u20131121. https:\/\/doi.org\/10.1016\/j.ijcard.2015.11.099","journal-title":"Int J Cardiol"},{"issue":"15","key":"10139_CR146","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1161\/CIRCULATIONAHA.113.002518","volume":"128","author":"A Gulati","year":"2013","unstructured":"Gulati A, Ismail TF, Jabbour A et al (2013) The prevalence and prognostic significance of right ventricular systolic dysfunction in nonischemic dilated cardiomyopathy. Circulation 128(15):1623\u20131633. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.002518","journal-title":"Circulation"},{"issue":"9","key":"10139_CR147","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.jcmg.2016.01.027","volume":"9","author":"M Merlo","year":"2016","unstructured":"Merlo M, Gobbo M, Stolfo D et al (2016) The prognostic impact of the evolution of RV function in idiopathic DCM. JACC Cardiovasc Imaging 9(9):1034\u20131042. https:\/\/doi.org\/10.1016\/j.jcmg.2016.01.027","journal-title":"JACC Cardiovasc Imaging"},{"issue":"11","key":"10139_CR148","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1111\/pace.12731","volume":"38","author":"D Stolfo","year":"2015","unstructured":"Stolfo D, Tonet E, Barbati G et al (2015) Acute hemodynamic response to cardiac resynchronization in dilated cardiomyopathy: effect on late mitral regurgitation. Pacing Clin Electrophysiol PACE 38(11):1287\u20131296. https:\/\/doi.org\/10.1111\/pace.12731","journal-title":"Pacing Clin Electrophysiol PACE"},{"issue":"8","key":"10139_CR149","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.amjcard.2015.01.549","volume":"115","author":"D Stolfo","year":"2015","unstructured":"Stolfo D, Merlo M, Pinamonti B et al (2015) Early improvement of functional mitral regurgitation in patients with idiopathic dilated cardiomyopathy. Am J Cardiol 115(8):1137\u20131143. https:\/\/doi.org\/10.1016\/j.amjcard.2015.01.549","journal-title":"Am J Cardiol"},{"issue":"11","key":"10139_CR150","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.118.005220","volume":"11","author":"JAJ Verdonschot","year":"2018","unstructured":"Verdonschot JAJ, Hazebroek MR, Wang P et al (2018) Clinical phenotype and genotype associations with improvement in left ventricular function in dilated cardiomyopathy. Circ Heart Fail 11(11):e005220. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.118.005220","journal-title":"Circ Heart Fail"},{"issue":"21","key":"10139_CR151","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1136\/heartjnl-2016-311017","volume":"103","author":"M Dal Ferro","year":"2017","unstructured":"Dal Ferro M, Stolfo D, Altinier A et al (2017) Association between mutation status and left ventricular reverse remodelling in dilated cardiomyopathy. Heart Br Card Soc 103(21):1704\u20131710. https:\/\/doi.org\/10.1136\/heartjnl-2016-311017","journal-title":"Heart Br Card Soc"},{"key":"10139_CR152","doi-asserted-by":"publisher","unstructured":"Merlo M, Stolfo D, Anzini M et al (2015) Persistent recovery of normal left ventricular function and dimension in idiopathic dilated cardiomyopathy during long\u2010term follow\u2010up: does real healing exist? J Am Heart Assoc Cardiovasc Cerebrovasc Dis 4(1). https:\/\/doi.org\/10.1161\/JAHA.114.001504","DOI":"10.1161\/JAHA.114.001504"},{"issue":"23","key":"10139_CR153","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1016\/j.jacc.2019.10.011","volume":"74","author":"D Fatkin","year":"2019","unstructured":"Fatkin D, Huttner IG, Kovacic JC, Seidman JG, Seidman CE (2019) Precision medicine in the management of dilated cardiomyopathy. J Am Coll Cardiol 74(23):2921\u20132938. https:\/\/doi.org\/10.1016\/j.jacc.2019.10.011","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10139_CR154","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cardfail.2018.03.004","volume":"24","author":"RE Hershberger","year":"2018","unstructured":"Hershberger RE, Givertz MM, Ho CY et al (2018) Genetic evaluation of cardiomyopathy\u2014a Heart Failure Society of America Practice Guideline. J Card Fail 24(5):281\u2013302. https:\/\/doi.org\/10.1016\/j.cardfail.2018.03.004","journal-title":"J Card Fail"},{"issue":"7","key":"10139_CR155","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.jacc.2018.05.065","volume":"72","author":"E Gandjbakhch","year":"2018","unstructured":"Gandjbakhch E, Redheuil A, Pousset F, Charron P, Frank R (2018) Clinical diagnosis, imaging, and genetics of arrhythmogenic right ventricular cardiomyopathy\/dysplasia. J Am Coll Cardiol 72(7):784\u2013804. https:\/\/doi.org\/10.1016\/j.jacc.2018.05.065","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10139_CR156","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1002\/ejhf.1815","volume":"22","author":"G Finocchiaro","year":"2020","unstructured":"Finocchiaro G, Merlo M, Sheikh N et al (2020) The electrocardiogram in the diagnosis and management of patients with dilated cardiomyopathy. Eur J Heart Fail 22(7):1097\u20131107. https:\/\/doi.org\/10.1002\/ejhf.1815","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"10139_CR157","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/ng815","volume":"30","author":"B Gerull","year":"2002","unstructured":"Gerull B, Gramlich M, Atherton J et al (2002) Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy. Nat Genet 30(2):201\u2013204. https:\/\/doi.org\/10.1038\/ng815","journal-title":"Nat Genet"},{"key":"10139_CR158","doi-asserted-by":"publisher","unstructured":"Akhtar MM, Lorenzini M, Cicerchia M et al (2020) Clinical phenotypes and prognosis of dilated cardiomyopathy caused by truncating variants in the TTN gene. Circ Heart Fail 13(10). https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.119.006832","DOI":"10.1161\/CIRCHEARTFAILURE.119.006832"},{"issue":"19","key":"10139_CR159","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1016\/j.jacc.2017.03.530","volume":"69","author":"U Tayal","year":"2017","unstructured":"Tayal U, Newsome S, Buchan R et al (2017) Truncating variants in titin independently predict early arrhythmias in patients with dilated cardiomyopathy. J Am Coll Cardiol 69(19):2466\u20132468. https:\/\/doi.org\/10.1016\/j.jacc.2017.03.530","journal-title":"J Am Coll Cardiol"},{"issue":"19","key":"10139_CR160","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1016\/j.jacc.2018.08.2171","volume":"72","author":"C Vasilescu","year":"2018","unstructured":"Vasilescu C, Ojala TH, Brilhante V et al (2018) Genetic basis of severe childhood-onset cardiomyopathies. J Am Coll Cardiol 72(19):2324\u20132338. https:\/\/doi.org\/10.1016\/j.jacc.2018.08.2171","journal-title":"J Am Coll Cardiol"},{"key":"10139_CR161","doi-asserted-by":"publisher","unstructured":"Frank D, Rangrez AY, Friedrich C et al (2019) Cardiac \u03b1-Actin ( ACTC1 ) gene mutation causes atrial-septal defects associated with late-onset dilated cardiomyopathy. Circ Genomic Precis Med 12(8). https:\/\/doi.org\/10.1161\/CIRCGEN.119.002491","DOI":"10.1161\/CIRCGEN.119.002491"},{"issue":"11","key":"10139_CR162","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1016\/j.jacc.2003.10.021","volume":"42","author":"M Vatta","year":"2003","unstructured":"Vatta M, Mohapatra B, Jimenez S et al (2003) Mutations in Cypher\/ZASP in patients with dilated cardiomyopathy and left ventricular non-compaction. J Am Coll Cardiol 42(11):2014\u20132027. https:\/\/doi.org\/10.1016\/j.jacc.2003.10.021","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10139_CR163","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1161\/CIRCGENETICS.115.001026","volume":"8","author":"MN Bainbridge","year":"2015","unstructured":"Bainbridge MN, Davis EE, Choi W-Y et al (2015) Loss of function mutations in NNT are associated with left ventricular noncompaction. Circ Cardiovasc Genet 8(4):544\u2013552. https:\/\/doi.org\/10.1161\/CIRCGENETICS.115.001026","journal-title":"Circ Cardiovasc Genet"},{"issue":"1","key":"10139_CR164","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/s0006-291x(02)02374-4","volume":"298","author":"S Daehmlow","year":"2002","unstructured":"Daehmlow S, Erdmann J, Knueppel T et al (2002) Novel mutations in sarcomeric protein genes in dilated cardiomyopathy. Biochem Biophys Res Commun 298(1):116\u2013120. https:\/\/doi.org\/10.1016\/s0006-291x(02)02374-4","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10139_CR165","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1073\/pnas.1523918113","volume":"113","author":"KJ Carroll","year":"2016","unstructured":"Carroll KJ, Makarewich CA, McAnally J et al (2016) A mouse model for adult cardiac-specific gene deletion with CRISPR\/Cas9. Proc Natl Acad Sci U S A 113(2):338\u2013343. https:\/\/doi.org\/10.1073\/pnas.1523918113","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"23","key":"10139_CR166","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1056\/NEJM200012073432304","volume":"343","author":"M Kamisago","year":"2000","unstructured":"Kamisago M, Sharma SD, DePalma SR et al (2000) Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N Engl J Med 343(23):1688\u20131696. https:\/\/doi.org\/10.1056\/NEJM200012073432304","journal-title":"N Engl J Med"},{"key":"10139_CR167","doi-asserted-by":"publisher","first-page":"232640981456713","DOI":"10.1177\/2326409814567131","volume":"3","author":"M Borkar","year":"2015","unstructured":"Borkar M, Bijarnia-Mahay S, Kohli S et al (2015) Identification of a novel TAZ gene mutation in a family with X-linked dilated cardiomyopathy Barth syndrome. J Inborn Errors Metab Screen 3:232640981456713. https:\/\/doi.org\/10.1177\/2326409814567131","journal-title":"J Inborn Errors Metab Screen"},{"issue":"10","key":"10139_CR168","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1016\/j.jacc.2004.08.027","volume":"44","author":"J Mogensen","year":"2004","unstructured":"Mogensen J, Murphy RT, Shaw T et al (2004) Severe disease expression of cardiac troponin C and T mutations in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 44(10):2033\u20132040. https:\/\/doi.org\/10.1016\/j.jacc.2004.08.027","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10139_CR169","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1161\/CIRCRESAHA.109.196055","volume":"105","author":"S Carballo","year":"2009","unstructured":"Carballo S, Robinson P, Otway R et al (2009) Identification and functional characterization of cardiac troponin I as a novel disease gene in autosomal dominant dilated cardiomyopathy. Circ Res 105(4):375\u2013382. https:\/\/doi.org\/10.1161\/CIRCRESAHA.109.196055","journal-title":"Circ Res"},{"issue":"4","key":"10139_CR170","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1006\/jmcc.2000.1339","volume":"33","author":"TM Olson","year":"2001","unstructured":"Olson TM, Kishimoto NY, Whitby FG, Michels VV (2001) Mutations that alter the surface charge of alpha-tropomyosin are associated with dilated cardiomyopathy. J Mol Cell Cardiol 33(4):723\u2013732. https:\/\/doi.org\/10.1006\/jmcc.2000.1339","journal-title":"J Mol Cell Cardiol"},{"issue":"23","key":"10139_CR171","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1056\/NEJM199912023412302","volume":"341","author":"D Fatkin","year":"1999","unstructured":"Fatkin D, MacRae C, Sasaki T et al (1999) Missense mutations in the rod domain of the lamin A\/C gene as causes of dilated cardiomyopathy and conduction-system disease. N Engl J Med 341(23):1715\u20131724. https:\/\/doi.org\/10.1056\/NEJM199912023412302","journal-title":"N Engl J Med"},{"issue":"20","key":"10139_CR172","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1016\/j.jacc.2018.08.2181","volume":"72","author":"F Dom\u00ednguez","year":"2018","unstructured":"Dom\u00ednguez F, Cuenca S, Bili\u0144ska Z et al (2018) Dilated cardiomyopathy due to BLC2-associated athanogene 3 (BAG3) mutations. J Am Coll Cardiol 72(20):2471\u20132481. https:\/\/doi.org\/10.1016\/j.jacc.2018.08.2181","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10139_CR173","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1186\/s13059-014-0534-8","volume":"15","author":"RC Deo","year":"2014","unstructured":"Deo RC, Musso G, Tasan M et al (2014) Prioritizing causal disease genes using unbiased genomic features. Genome Biol 15(12):534. https:\/\/doi.org\/10.1186\/s13059-014-0534-8","journal-title":"Genome Biol"},{"key":"10139_CR174","doi-asserted-by":"publisher","unstructured":"Milting H, Klauke B, Christensen AH et al (2015) The TMEM43 Newfoundland mutation p.S358L causing ARVC-5 was imported from Europe and increases the stiffness of the cell nucleus. Eur Heart J 36(14):872\u2013881. https:\/\/doi.org\/10.1093\/eurheartj\/ehu077","DOI":"10.1093\/eurheartj\/ehu077"},{"issue":"6","key":"10139_CR175","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1172\/JCI17892","volume":"111","author":"K Haghighi","year":"2003","unstructured":"Haghighi K, Kolokathis F, Pater L et al (2003) Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human. J Clin Invest 111(6):869\u2013876. https:\/\/doi.org\/10.1172\/JCI17892","journal-title":"J Clin Invest"},{"issue":"21","key":"10139_CR176","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1136\/hrt.2011.227967","volume":"97","author":"P Garcia-Pavia","year":"2011","unstructured":"Garcia-Pavia P, Syrris P, Salas C et al (2011) Desmosomal protein gene mutations in patients with idiopathic dilated cardiomyopathy undergoing cardiac transplantation: a clinicopathological study. Heart Br Card Soc 97(21):1744\u20131752. https:\/\/doi.org\/10.1136\/hrt.2011.227967","journal-title":"Heart Br Card Soc"},{"issue":"4","key":"10139_CR177","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1001\/jama.293.4.447","volume":"293","author":"TM Olson","year":"2005","unstructured":"Olson TM, Michels VV, Ballew JD et al (2005) Sodium channel mutations and susceptibility to heart failure and atrial fibrillation. JAMA 293(4):447\u2013454. https:\/\/doi.org\/10.1001\/jama.293.4.447","journal-title":"JAMA"},{"issue":"5","key":"10139_CR178","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1161\/01.cir.100.5.461","volume":"100","author":"D Li","year":"1999","unstructured":"Li D, Tapscoft T, Gonzalez O et al (1999) Desmin mutation responsible for idiopathic dilated cardiomyopathy. Circulation 100(5):461\u2013464. https:\/\/doi.org\/10.1161\/01.cir.100.5.461","journal-title":"Circulation"},{"issue":"11","key":"10139_CR179","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1016\/j.hrthm.2009.07.041","volume":"6","author":"JP van Tintelen","year":"2009","unstructured":"van Tintelen JP, Van Gelder IC, Asimaki A et al (2009) Severe cardiac phenotype with right ventricular predominance in a large cohort of patients with a single missense mutation in the DES gene. Heart Rhythm 6(11):1574\u20131583. https:\/\/doi.org\/10.1016\/j.hrthm.2009.07.041","journal-title":"Heart Rhythm"},{"key":"10139_CR180","doi-asserted-by":"publisher","unstructured":"Ben Yaou R, Gerard M, Chami K et al (2014) G.P.142. Neuromuscul Disord 24(9\u201310):843\u2013844. https:\/\/doi.org\/10.1016\/j.nmd.2014.06.172","DOI":"10.1016\/j.nmd.2014.06.172"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-021-10139-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-021-10139-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-021-10139-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T22:58:41Z","timestamp":1744153121000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-021-10139-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,14]]},"references-count":180,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["10139"],"URL":"https:\/\/doi.org\/10.1007\/s10741-021-10139-0","relation":{},"ISSN":["1382-4147","1573-7322"],"issn-type":[{"value":"1382-4147","type":"print"},{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,14]]},"assertion":[{"value":"30 June 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}